MEDTRONIC IRELAND VALIANT STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
|
Back to Search Results |
|
Model Number UNK-CV-SR-VALIANT |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Intimal Dissection (1333); Aneurysm (1708); Chest Pain (1776); Hematoma (1884); Neurological Deficit/Dysfunction (1982); Pain (1994); Rupture (2208)
|
Event Date 07/11/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
Medtronic received the following information obtained from the journal article entitled: outcomes of type a intramural hematoma: influence of diabetes mellitus chen et al, j card surg.2020; 35: 1811¿ 1821.Https://doi.Org/10.1111/jocs.14812.Sex: mean gender.Implant date: exact date of implant unknown.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Valiant stent grafts were implanted in conjunction with non mdt stent grafts in patients during tevar on unknown dates.The following adverse events were reported: type a aortic dissection, neurological complication, chest pain, back pain, hematoma thickening, ulcer-like projection and aortic aneurysm development and aortic rupture.The cause of the adverse events are undetermined.
|
|
Manufacturer Narrative
|
Additional information received: it was reported that none of the adverse events reported in the study were directly related to the valiant stent grafts.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|